摘要
Background & Aim Hepatitis B reactivation related to the use of immunosuppressive therapy remains a major cause of liver-related morbidity and mortality in hepatitis B endemic Asia-Pacific region. This clinical practice guidelines aim to assist clinicians in all disciplines involved in the use of immunosuppressive therapy to effectively prevent and manage hepatitis B reactivation. Methods All publications related to hepatitis B reactivation with the use of immunosuppressive therapy since 1975 were reviewed. Advice from key opinion leaders in member countries/administrative regions of Asian-Pacific Association for the study of the liver was collected and synchronized. Immunosuppressive therapy was risk-stratified according to its reported rate of hepatitis B reactivation. Recommendations We recommend the necessity to screen all patients for hepatitis B prior to the initiation of immunosuppressive therapy and to administer pre-emptive nucleos(t)ide analogues to those patients with a substantial risk of hepatitis and acute-on-chronic liver failure due to hepatitis B reactivation.
学科与关键词
- APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (vol 15, pg 1031, 2021)Lau, George*; Yu, Ming-Lung*; Wong, Grace; Thompson, Alexander; Ghazinian, Hasmik; Hou, Jin-Lin; Piratvisuth, Teerha; Jia, Ji-Dong; Mizokami, Masashi; Cheng, Gregory; Chen, Guo-Feng; Liu, Zhen-Wen; Baatarkhuu, Oidov; Cheng, Ann Lii; Ng, Woon Leung; Lau, Patrick; Mok, Tony; Chang, Jer-Ming; Hamid, Saeed; Dokmeci, A. Kadir; Gani, Rino A.; Payawal, Diana A.; Chow, Pierce; Park, Joong-Won; Strasser, Simone I.; Mohamed, Rosmawaiti; Win, Khin Maung; Tanwandee, TawesakHepatology International, 2022, 16(2): 486-487.
- Hepatitis B Virus Reactivation Increased the Risk of Developing Hepatic Failure and Mortality in Cirrhosis With Acute ExacerbationZhu, Ying; Li, Hai; Wang, Xianbo; Zheng, Xin; Huang, Yan; Chen, Jinjun; Meng, Zhongji; Gao, Yanhang; Qian, Zhiping; Liu, Feng; Lu, Xiaobo; Shi, Yu; Shang, Jia; Yan, Huadong; Zheng, Yubao; Qiao, Liang; Zhang, Yan; Xiang, Xiaomei; Dan, Yunjie; Sun, Shuning; Hou, Yixin; Zhang, Qun; Xiong, Yan; Li, Sumeng; Chen, Jun; Huang, Zebing; Li, Beiling; Jiang, Xiuhua; Luo, Sen; Chen, Yuanyuan; Gao, Na; Liu, Chunyan; Ji, Liujuan; Yuan, Wei; Li, Jing; Li, Tao; Zheng, Rongjiong; Zhou, Xinyi; Ren, HaotangFrontiers in Microbiology, 2022, 13: 910549.被引 3
- 使用免疫抑制剂的肾病患者抗乙肝的治疗分析李新新; 万波; 黄志军; 黄素铷; 刘双信; 劳海燕今日药学, 2013, (06): 355.
